AzTrials
AzTrials

Pregnancy PreventionPhase 2HATNCT03194672

Healthy Adolescent Transitions (HAT)

A Phase 2 study testing Healthy Adolescent Transitions (HAT) program in people with Pregnancy Prevention and Life Skill Development, run by Jack Stevens at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Randomized trial of a rapid repeat pregnancy prevention program for adolescent mothers. Five hundred adolescent mothers from central Ohio will be enrolled--half will be assigned to an intervention that features nurses and social workers providing extra assistance during late pregnancy and the early postnatal period… Read more about this study

Who is it for?
Ages 14 to 19 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy Prevention, Life Skill Development
What is being tested?
Healthy Adolescent Transitions (HAT) program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
331 participants
Where
1 siteUnited States
Study dates
14 Aug 2017to 2 Mar 2024
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 19 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Age 14-19 years
  • 24-35 weeks gestation
  • Medicaid insurance
  • Central Ohio resident
  • English speaking
  • Ability to provide informed consent (18-19 years of age) or minor assent and parental consent (<18 years of age)
Show all 9Show fewer
  • Willingness to complete study-related surveys and coaching sessions
  • Patient must have her own smartphone, capable of running the study-related mobile application
  • Patient must have regular access to cellular or WiFi service

Who cannot join

  • Patients < 13 years or >19 years
  • Non-English speaking
  • <24 or >35 weeks of gestation
  • Primary residence is located outside of central Ohio
  • Another adolescent from the household has already been enrolled in the program

Trial locations and contacts

1 site in 1 country.

United States1 site
  • OhioHealth Innovation Institute

    Columbus, Ohio, 43205

Other trials in United States

About this study

Official title: Healthy Adolescent Transitions (HAT): A Comprehensive Approach to Targeting Adolescent Mothers

Randomized trial of a rapid repeat pregnancy prevention program for adolescent mothers.

Five hundred adolescent mothers from central Ohio will be enrolled--half will be assigned to an intervention that features nurses and social workers providing extra assistance during late pregnancy and the early postnatal period and half will be assigned to a standard of care intervention.

OhioHealth is the lead entity. Nationwide Children's Hospital serves as the local independent evaluator.

This federally funded contract is supported by the Family and Youth Services Bureau.

Being tested
Healthy Adolescent Transitions (HAT) program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Healthy Adolescent Transitions (HAT) programBehavioural

    The components of the intervention are described in the arm description.

    The intervention is based upon the theoretical framework of behavioral economics, which suggests that low intensity "nudges" can help recipients accomplish their own goals. All components of the intervention are voluntary; some participants may wish to discuss all components, while other participants may wish to discuss selected components consistent with their priorities.

Study groups in NCT03194672
Study groupRoleWhat they receive
Intervention ConditionExperimentalThis experimental condition has three major components: 1. Individual sessions: Roughly 12 90-minute sessions over 3 months Prenatal sessions covering contraceptive options, including long-acting reversible contraception. Prenatal and postnatal sessions will also cover (a) financial benefits of smoking cessation; (b)financial literacy/budgeting skills based upon selected components of the Money Matters curriculum; (c) establishing concrete steps to reach educational/career goals; (d) healthy eating habits; and (e) importance of HPV vaccinations and getting a medical home. 2. Transportation assistance for medical home appointments. 3. Electronic Prompts/Reminders to Encourage Completion of Goals.
Receives: Behavioral: Healthy Adolescent Transitions (HAT) program
Treatment as Usual Control ConditionNo interventionThe comparison group will be a Usual Care control group. The control group will have access to standard medical and behavior health services as part of routine care. Prior to randomization, each enrolled participant will receive a listing of contact information for organizations offering this routine care. The only interaction the HAT providers will have with control group participants is to have periodic and brief phone conversations in which updated changes in contact information will be collected. The HAT providers will also obtain updated changes in contact information for HAT intervention group participants.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Long acting reversible contraception

    Use of long acting reversible contraception

    Measured: 12 months post enrollment

  2. Repeat pregnancy

    Repeat pregnancy

    Measured: 21 months post enrollment

Secondary outcomes (6)
  1. Nicotine use

    Use of cigarettes and vapor products

    Measured: 21 months post enrollment

  2. Financial literacy

    Understanding of financial terminology

    Measured: 21 months post enrollment

  3. School completion

    Highest grade completed

    Measured: 21 months post enrollment

  4. Medical home

    Use of primary care services

    Measured: 21 months post enrollment

  5. Healthy eating behaviors

    Eating nutritional food according to items from Youth Risk Behavior Survey

    Measured: 21 months post enrollment

  6. Employment

    Number of hours worked per week

    Measured: 21 months post enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2017
  2. Study start14 Aug 2017
  3. Primary completion2 Mar 2024
  4. Study completion2 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
331 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03194672
Sponsor's protocol ID
90AP2678-01-00
Acronym
HAT
Status last verified
Mar 2024
First submitted
19 Jun 2017
Last updated
25 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: de-identified data base will be available at conclusion of the study

Publications

  • Stevens J, Rausch J, Osuagwu N, Lutz R. Efficacy of Behavioral Economic Nudges to Assist Teen Mothers: the Healthy Adolescent Transitions Randomized Controlled Trial. Prev Sci. 2024 Apr;25(3):509-520. doi: 10.1007/s11121-024-01660-3. Epub 2024 Mar 2.

    PubMed 38429618

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Healthy Adolescent Transitions (HAT) program in people with Pregnancy Prevention and Life Skill Development, run by Jack Stevens at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Long acting reversible contraception (time frame: 12 months post enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03194672, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in